Minocycline in Patients With Alzheimer's Disease

NCT01463384 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Mild Cognitive Impairment
Alzheimer's Disease

Interventions

DRUG: Minocycline

Sponsor

Huntington Medical Research Institutes